全文获取类型
收费全文 | 151篇 |
免费 | 1篇 |
专业分类
儿科学 | 5篇 |
妇产科学 | 1篇 |
基础医学 | 10篇 |
口腔科学 | 2篇 |
临床医学 | 22篇 |
内科学 | 29篇 |
皮肤病学 | 1篇 |
神经病学 | 8篇 |
特种医学 | 7篇 |
外科学 | 23篇 |
综合类 | 7篇 |
预防医学 | 7篇 |
眼科学 | 1篇 |
药学 | 23篇 |
中国医学 | 2篇 |
肿瘤学 | 4篇 |
出版年
2023年 | 1篇 |
2022年 | 2篇 |
2021年 | 1篇 |
2020年 | 2篇 |
2019年 | 10篇 |
2018年 | 18篇 |
2017年 | 8篇 |
2015年 | 4篇 |
2014年 | 17篇 |
2013年 | 12篇 |
2012年 | 5篇 |
2011年 | 12篇 |
2010年 | 5篇 |
2009年 | 7篇 |
2008年 | 9篇 |
2007年 | 8篇 |
2006年 | 7篇 |
2005年 | 4篇 |
2003年 | 1篇 |
2002年 | 1篇 |
2001年 | 2篇 |
2000年 | 3篇 |
1999年 | 3篇 |
1998年 | 2篇 |
1994年 | 1篇 |
1989年 | 1篇 |
1985年 | 4篇 |
1984年 | 1篇 |
1976年 | 1篇 |
排序方式: 共有152条查询结果,搜索用时 15 毫秒
81.
Lisa B. Liu Mario A. Cedillo Vivian Bishay Mona Ranade Rahul S. Patel Edward Kim Scott F. Nowakowski Robert A. Lookstein Aaron M. Fischman 《Journal of vascular and interventional radiology : JVIR》2019,30(3):414-420
Purpose
To determine patient preference for transradial access (TRA) or transfemoral access (TFA) after experiencing both.Materials and Methods
A randomized controlled crossover trial was conducted at a single institution. Thirty patients with hepatocellular carcinoma undergoing mapping and transarterial radioembolization (TARE) were enrolled to experience 1 TRA and 1 TFA procedure each, with randomization of which access approach was experienced first. Surveys assessing pain and quality of life (QOL) were administered after each procedure. Access site preference was collected after completion of both procedures.Results
Twenty-two subjects (73.3%) preferred TRA, 4 (13.3%) preferred TFA, and 4 (13.3%) had no preference; 14 (46.7%) reported bruising after TRA, and 17 (53.3%) reported bruising after TFA. TRA was associated with significantly lower pain scores overall during the procedure, at the access site during the procedure, and in the recovery room compared with TFA (2.0 vs 2.9, P = .0046; 2.0 vs 3.0, P = .0004; 2.1 vs 2.9, P = .0357). Pain score after discharge was not significantly different (1.4 vs 1.5, P = .4235). QOL scores were not significantly different between TRA and TFA. No significant differences were found for fluoroscopy time, air kerma, dose-area product, or procedure time between TRA and TFA for either mapping (P = .1442, P = .5871, P = .6667, P = .6131) or radioembolization (P = .8574, P = .2344, P = .1119, P =.8474). For radioembolizations, TRA had significantly shorter recovery times compared with TFA (108 min vs 153 min, P = .0193).Conclusions
Patients exhibited a strong preference for TRA. With TRA, patients experienced less periprocedural pain and shorter recovery times without significant differences in radiation exposure or procedure length. 相似文献82.
《European journal of pharmaceutics and biopharmaceutics》2014,86(3):1325-1336
Polymeric micelles provide a promising platform for improving oral absorption of poorly soluble drugs. However, improved understanding of how drug retention within the hydrophobic micelle core can reduce drug absorption is required. We designed supersaturated polymeric micelles (Super-PMs) to increase molecularly dissolved drug concentration and gain an insight into the effect of the degree of supersaturation on oral absorption of cyclosporine A (CsA) in rats. The drug release from Super-PMs increased with an increase in initial supersaturation degrees in micelles. The cellular uptake of coumarin-6 was reduced by the retention of drug in polymer micelles. The transport flux of CsA across Caco-2 monolayer was increased with initial supersaturation degrees of 0.81–3.53 (p < 0.05). However, increase in supersaturation to 5.64 actually resulted in decreased CsA transport. The same trend was observed in a rat in vivo absorption study, in which the highest bioavailability of 134.6 ± 24.7% (relative to a commercial product, Sandimmun Neoral®, p < 0.01) was achieved when the supersaturation degree was 3.53. These results demonstrated that Super-PMs were a promising drug delivery system for compounds with low aqueous solubility. This study also provided an experimental proof for the hypothesis that moderately supersaturated formulations are valuable alternative to high supersaturation formulations, resulting in optimal in vivo performance, and the degree of supersaturation should be carefully controlled to optimize drug absorption. 相似文献
83.
目的探讨经皮股动脉导管药盒系统介入治疗肝细胞癌的临床疗效及并发症。方法从1999年1月到2001年3月应用经皮股动脉植入导管药盒系统(PCS)对45例肝细胞癌患者进行化疗和碘油栓塞治疗,回顾性分析临床疗效及并发症。结果PCS介入治疗肝细胞癌的有效率为66.7%(30/45)。患者1、2、3年生存率为75.6%(34/45),33.3%(15/45),17.8%(8/45)。弪皮股动脉导管药盒植入术的并发症包括1例切口感染及切口延迟愈合,4例PCS堵塞和1例留置导管尖移位。所有并发症经适当处理后无严重后遗症。结论经皮股动脉导管药盒系统植入术对介入治疗肝细胞性肝癌是1种安全有效技术。 相似文献
84.
The effects of chronic oral ingestion of lead in doses ranging from 20–80 ppm were compared with those seen after the subacute exposure of rats to a 10 mg/kg daily dose of the heavy metal for 7 days. Irrespective of the treatment regimen used, lead treatment significantly increased the activities of renal pyruvate carboxylase, phosphoenopyruvate carboxykinase, fructose 1,6-diphosphatase and glucose 6-phosphatase. The observed enhancement of kidney gluconeogenic enzymes in chronically treated animal was associated with a stimulation of the adenylate cyclase-cyclic AMP system, a rise in blood glucose and urea as well as a depression in hepatic glycogen and serum immunoreactive insulin (IRI) levels. In contrast, subacute exposure to lead failed to significantly alter cyclic AMP metabolism and the concentrations of liver glycogen, blood glucose, serum urea or IRI. Whereas the insulinogenic index (the ratio of serum IRI to blood concentration) was markedly suppressed in chronically treated rats, this ratio remained within normal limits following subacute exposure to the heavy metal. However, a marked decrease in the insulinogenic index was observed in subacutely treated rats 15 min after the administration of a glucose load. The data provide evidence to show that increased glucose synthesis as well as suppressed pancreatic function may be responsible for lead-induced disturbances in glucose homeostasis. 相似文献
85.
86.
87.
目的探讨植入式导管药盒化疗与髂内动脉插管介入化疗对中晚期宫颈癌的疗效。方法中晚期宫颈癌患者81例.随机分为动脉药盒组(PCS)(治疗组)和介入栓塞组(TACE)(对照组),手术或放疗前分别给予PCS和TACE化疗。结果(1)治疗组和对照组病人近期临床总有效率分别为90.0%、70.73%;手术率分别为85.0%、65.85%;骨髓抑制和胃肠道毒副反应分别为37.5%、67.3%和61.0%、87.8%;治疗费用及住院时间两组比较.差异有统计学意义(P〈0.05)。(2)两组病人复发率及生存率分别比较,差异无统计学意义(P〉0.05)。结论PCS栓塞化疗治疗中晚期宫颈癌近期有效率明显提高,毒副作用减少,具有广阔的应用前景。 相似文献
88.
Zgoda-Pols JR Chowdhury S Wirth M Milburn MV Alexander DC Alton KB 《Toxicology and applied pharmacology》2011,255(1):48-56
An investigative renal toxicity study using metabolomics was conducted with a potent nicotinic acid receptor (NAR) agonist, SCH 900424. Liquid chromatography-mass spectrometry (LC-MS) and gas chromatography-mass spectrometry (GC-MS) techniques were used to identify small molecule biomarkers of acute kidney injury (AKI) that could aid in a better mechanistic understanding of SCH 900424-induced AKI in mice. The metabolomics study revealed 3-indoxyl sulfate (3IS) as a more sensitive marker of SCH 900424-induced renal toxicity than creatinine or urea. An LC-MS assay for quantitative determination of 3IS in mouse matrices was also developed. Following treatment with SCH 900424, 3IS levels were markedly increased in murine plasma and brain, thereby potentially contributing to renal- and central nervous system (CNS)-related rapid onset of toxicities. Furthermore, significant decrease in urinary excretion of 3IS in those animals due to compromised renal function may be associated with the elevation of 3IS in plasma and brain. These data suggest that 3IS has a potential to be a marker of renal and CNS toxicities during chemically-induced AKI in mice. In addition, based on the metabolomic analysis other statistically significant plasma markers including p-cresol-sulfate and tryptophan catabolites (kynurenate, kynurenine, 3-indole-lactate) might be of toxicological importance but have not been studied in detail. This comprehensive approach that includes untargeted metabolomic and targeted bioanalytical sample analyses could be used to investigate toxicity of other compounds that pose preclinical or clinical development challenges in a pharmaceutical discovery and development. 相似文献
89.
High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: Quality by design optimization and characterization 总被引:1,自引:0,他引:1
Dongmei Cun Ditte Krohn Jensen Morten Jonas Maltesen Matthew BunkerPaul Whiteside David ScurrCamilla Foged Hanne Mørck Nielsen 《European journal of pharmaceutics and biopharmaceutics》2011,77(1):26-35
Poly(dl-lactide-co-glycolide acid) (PLGA) is an attractive polymer for delivery of biopharmaceuticals owing to its biocompatibility, biodegradability and outstanding controlled release characteristics. The purpose of this study was to understand and define optimal parameters for preparation of small interfering RNA (siRNA)-loaded PLGA nanoparticles by the double emulsion solvent evaporation method and characterize their properties. The experiments were performed according to a 25−1 fractional factorial design based on five independent variables: The volume ratio between the inner water phase and the oil phase, the PLGA concentration, the sonication time, the siRNA load and the amount of acetylated bovine serum albumin (Ac-BSA) in the inner water phase added to stabilize the primary emulsion. The effects on the siRNA encapsulation efficiency and the particle size were investigated. The most important factors for obtaining an encapsulation efficiency as high as 70% were the PLGA concentration and the volume ratio whereas the size was mainly affected by the PLGA concentration. The viscosity of the oil phase was increased at high PLGA concentration, which explains the improved encapsulation by stabilization of the primary emulsion and reduction of siRNA leakage to the outer water phase. Addition of Ac-BSA increased the encapsulation efficiency at low PLGA concentrations. The PLGA matrix protected siRNA against nuclease degradation, provided a burst release of surface-localized siRNA followed by a triphasic sustained release for two months. These results enable careful understanding and definition of optimal process parameters for preparation of PLGA nanoparticles encapsulating high amounts of siRNA with immediate and long-term sustained release properties. 相似文献
90.
动脉药盒植入系统治疗肝癌发生堵塞的预防与处理 总被引:1,自引:0,他引:1
目的探讨动脉药盒植入系统治疗肝癌发生堵塞的预防与处理方法。材料与方法107例晚期肝癌患者行介入手术经皮经股动脉或经皮经锁骨下动脉于肝固有动脉内植入动脉药盒系统107个,进行随访,主要对动脉药盒系统堵塞的发生情况进行观察并总结预防与处理方法。结果动脉药盒系统植入术后的发生堵塞有8个,发生率为7.48%(8/107),经肝素生理盐水溶液冲洗动脉药盒系统或/和高浓度尿激酶溶液动脉药盒系统内推注(部分在胃肠X光机或DSA机下进行)后复通率为75.00%(6/8)。结论在胃肠X光机或DSA机下进行肝素生理盐水溶液冲洗动脉药盒系统或/和高浓度尿激酶溶液动脉药盒系统内推注是处理堵塞的有效办法。 相似文献